Keros Therapeutics, Inc. (KROS) Insider Trading
Sector: Biotechnology · Market Cap: $214M · 0 insider purchases in the last 7 days
No open market insider purchases at Keros Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track KROS on your watchlist.
Start for FreeAbout Keros Therapeutics, Inc. Insider Trading
1 insider at Keros Therapeutics, Inc. (KROS) has purchased stock in the past 90 days, totaling $10K across 1 transaction (1,000 shares).
The most recent purchase was by Director BIENAIME JEAN JACQUES on August 17, 2026 — a $10K buy of 1,000 shares at $10.27, bringing their total holdings to 19,592 shares.
KROS is in the Biotechnology sector within the Biotechnology industry with a market cap of $214M.
Track KROS insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.